Discussion
Blood tests measuring levels of neurofilament light chain (NfL), a biomarker of nerve damage, may help identify people who eventually develop amyotrophic lateral sclerosis (ALS) more than a decade in advance, according to a new study. Elevated levels of NfL — a protein that provides structural support…